Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Auto, metal and PSU bank shares advanced while FMCG, pharma shares declined.
At 09:25 IST, the barometer index, the S&P BSE Sensex advanced 161 points or 0.17% to 85,324.57. The Nifty 50 index added 51.65 points or 0.20% to 26,198.20.
In the broader market, the S&P BSE Mid-Cap index jumped 0.23% and the S&P BSE Small-Cap index gained 0.18%.
The market breadth was strong. On the BSE, 1,819 shares rose and 1,076 shares fell. A total of 156 shares were unchanged.
Foreign portfolio investors (FPIs) sold shares worth Rs 3,268.60 crore, while domestic institutional investors (DIIs) were net buyers to the tune of Rs 1,525.89 crore in the Indian equity market on 01 January 2026, provisional data showed.
Stocks in Spotlight:
RailTel Corporation of India rose 0.89%. The company has received a Letter of Acceptance (LoA) from the Assam Health Infrastructure Development & Management Society (AHIDMS) for procurement, implementation, and maintenance of a Hospital Management Information System (HMIS). The estimated order value is Rs 56.71 crore.
Aurobindo Pharma announced added 0.44%. The company that its subsidiary, Auro Pharma, has approved the acquisition of the non-oncology prescription formulations business of Khandelwal Laboratories on a going-concern basis through a Business Transfer Agreement for Rs 325 crore.
Time Technoplast added 2.66% after the company has received approvals from the Petroleum and Explosives Safety Organisation (PESO) and TÜV Rheinland (India) for the manufacture and supply of high-pressure Type-3 fully wrapped fiber-reinforced composite cylinders of 2-liter capacity for compressed gas applications.
Numbers to Track:
The yield on India's 10-year benchmark federal paper shed 0.03% to 6.579 as compared with the previous close of 6.581.
In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 89.9725 compared with its close of 89.9850 during the previous trading session.
MCX Gold futures for 5 February 2026 settlement rose 0.66% to Rs 136.704.
The US Dollar Index (DXY), which tracks the greenback's value against a basket of currencies, was down 0.16% to 98.17.
The United States 10-year bond yield rose 0.70% to 4.179.
In the commodities market, Brent crude for February 2025 settlement advanced 25 cents or 0.41% to $61.10 a barrel.
Global Markets:
South Korea’s Kospi hit a new record Friday as the Asia markets kicked off the new year on a positive trading note.
Some Asian markets were still closed for the holidays, including Japan and mainland China.
Meanwhile, Singapore’s economy expanded 5.7% year-on-year for the fourth quarter, driven mainly by strong manufacturing growth in the three months through December. The latest reading is faster than the revised 4.3% growth in the previous quarter.
On Wednesday, Prime Minister Lawrence Wong announced in his New Year message that the country had clocked a stronger-than-expected 4.8% expansion for the full year of 2025.
U.S. stock futures were looking up in early Asian hours, with S&P futures up by 0.15% and Nasdaq-100 futures climbing 0.12%. Dow Jones Industrial Average futures were 0.16% higher.
On Wednesday stateside, the S&P 500 dipped 0.74%, while the Nasdaq Composite fell 0.76% and the Dow Jones Industrial Average lost 0.63%.
The transaction was signed and completed on 1 January 2026. Under the agreement, Auro Pharma has acquired the branded non-oncology prescription formulations business of Khandelwal Laboratories as a going concern on a slump-sale basis. The acquisition includes inventory, intellectual property, employees, contracts, and other associated assets. The total cash consideration for the transaction is Rs 325 crore.
The acquisition is expected to strengthen the company’s pain management and anti-infective portfolio, complementing its existing offerings and supporting expansion in the domestic market.
Aurobindo Pharma is principally engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services.
The company’s consolidated net profit increased 3.8% to Rs 848.45 crore on 7.7% increase in net sales to Rs 8,236.96 crore in Q2 FY26 over Q2 FY25.
Aurobindo Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 1198.8, down 0.61% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.36% on the day, quoting at 25948.55. The Sensex is at 84699.55, down 0.4%.Aurobindo Pharma Ltd has eased around 1.43% in last one month.Meanwhile, Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has eased around 1.26% in last one month and is currently quoting at 22684.65, down 0.37% on the day. The volume in the stock stood at 2.55 lakh shares today, compared to the daily average of 6.38 lakh shares in last one month.
The benchmark December futures contract for the stock is quoting at Rs 1202.3, down 0.37% on the day. Aurobindo Pharma Ltd tumbled 7.66% in last one year as compared to a 9.74% rally in NIFTY and a 2.76% fall in the Nifty Pharma index.
The PE of the stock is 34.66 based on TTM earnings ending September 25.
At the end of the current inspection, a ‘Form 483' was issued with 05 observations which are procedural in nature, and we will respond to the US FDA within the stipulated timelines.
The scrip rose 0.36% to Rs 1,197.40 on the BSE.
IT, realty and consumer durables shares advanced while media, auto and pharma shares declined.
At 13:25 ST, the barometer index, the S&P BSE Sensex, climbed 90.46 points or 0.11% to 84,695.19. The Nifty 50 index added 57.05 points or 0.22% to 25,877.25.
In the broader market, the S&P BSE Mid-Cap index jumped 0.16% and the S&P BSE Small-Cap index fell 0.21%.
The market breadth was weak. On the BSE, 1,623 shares rose and 2,401 shares fell. A total of 188 shares were unchanged.
Gainers & Losers:
Interglobe Aviation (Indigo) (up 3.04%), Max Healthcare Institute (up 3.04%), Tata Consultancy Services (up 1.77%), Infosys (up 1.48%) and Hindalco Industries (up 1.26%) were the major Nifty50 gainers.
Sun Pharmaceuticals Industries (down 2.88%), Powergrid Corporation of India (down 1.72%), NTPC (down 1.04%), Mahindra% Mahindra (down 0.87%) and Bajaj-Auto (down 0.84%) were the major Nifty50 losers.
Max Healthcare Institute jumped 3.04% after the company announced that its board has approved the acquisition of of 100% equity stake in Yerawada Properties Private (YPPL), Pune, Maharashtra.
Sun Pharmaceutical Industries declined 2.88% after the company announced that the US FDA, post an audit, has determined the Baska facility inspection classification as Official Action Indicated (OAI).
IPO Update:
KSH International received bids for 53,72,991 shares as against 1,36,16,438 shares on offer, according to stock exchange data at 13:15 IST on Thursday (18 December 2025). The issue was subscribed 0.39 times. The issue opened for bidding on 16 December 2025 and it will close on 18 December 2025. The price band of the IPO is fixed between Rs 365 and 384 per share.
Shares of asset management companies jumped on Wednesday after SEBI on Wednesday (17 December 2025) decided to lower mutual fund expense ratio limits, now termed the Base Expense Ratio or BER. The BER will exclude all statutory levies such as GST, stamp duty, SEBI fees and exchange charges.
Nippon Life India Asset Management surged 4.64%. HDFC Asset Management Company surged 6.68%. UTI Asset Management Company gained 2.24%. Nuvama Wealth Management rose 1.96%. Aditya Birla Sun Life AMC advanced 1.36%, while Motilal Oswal Financial Services rallied 4.18%.
Alembic Pharmaceuticals declined 1.07%. The company announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Travoprost Ophthalmic Solution USP, 0.004% (ionic buffered solution).
Bajaj Electricals added 0.20%. The company announced that its management has decided to enter into the solar solutions business as a new and additional line under its Lighting Solutions segment.
Aurobindo Pharma advanced 1.57%. The company said that the US Food and Drug Administration (US FDA) has completed the inspection of APL Healthcare’s Unit-IV, wholly owned subsidiary, located at Palchur village, Andhra Pradesh (AP). At the end of the current inspection, a ‘Form 483’ was issued with 5 observations which are procedural in nature.
Antony Waste Handling Cell zoomed 14.88% after its subsidiary, AG Enviro Infra Projects, has bagged two contracts for collection & transportation of municipal solid waste (MSW) in Mumbai by the Brihanmumbai Municipal Corporation (BMC). The total value of the contracts is around Rs 1,330 crore.
GMR Power and Urban Infra shed 0.31%. The company said that its board has approved raising up to Rs 1,200 crore through the issuance of equity shares and convertible warrants to select investors on a preferential basis.
Most of European market advanced as traders prepare for central bank decisions today.
Most Asian stocks fell on Thursday, led by renewed weakness in technology stocks as lingering concerns over stretched artificial intelligence valuations resurfaced. Investor sentiment was further dampened by expectations of a hawkish stance from the Bank of Japan, adding to regional market pressure.
Artificial intelligence-related stocks dragged indexes after a media report stated that Oracle’s primary investor, Blue Owl Capital, has pulled out from funding one of its data center projects.
Over in Asia, the Bank of Japan will kick off its two-day meeting, with the central bank expected to raise rates to 0.75% Friday, its highest level in 30 years.
Overnight in the U.S., all three major indexes fell, with the S&P 500 down 1.16%, and the Nasdaq Composite seeing the largest loss of 1.81%. The Dow Jones Industrial Average slipped 0.47%.
Traders are awaiting the release of the U.S. consumer price index reading for November, due Thursday morning. It will mark the first consumer inflation report issued to the public since the government shutdown ended last month. Media reports stated that the headline inflation is expected to have grown at a pace of 3.1% on a year-over-year basis.
Aurobindo Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 1218.8, up 0.71% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.26% on the day, quoting at 25811.05. The Sensex is at 84221.24, down 0.3%. Aurobindo Pharma Ltd has gained around 9.9% in last one month.
Meanwhile, Nifty Pharma index of which Aurobindo Pharma Ltd is a constituent, has gained around 3.23% in last one month and is currently quoting at 22686.8, up 0.36% on the day. The volume in the stock stood at 10.7 lakh shares today, compared to the daily average of 13.98 lakh shares in last one month.
The benchmark November futures contract for the stock is quoting at Rs 1223.1, up 0.95% on the day. Aurobindo Pharma Ltd is down 1.34% in last one year as compared to a 10.05% jump in NIFTY and a 5.69% jump in the Nifty Pharma index.
The PE of the stock is 35.05 based on TTM earnings ending September 25.